icon-    folder.gif   Conference Reports for NATAP  
  IAS 2017: Conference on HIV Pathogenesis
Treatment and Prevention
Paris, France
July 23-26 2017
Back grey_arrow_rt.gif
Single doses as low as 0.5 mg of the novel NRTTI MK-8591 suppress HIV for at least seven days
  Reported by Jules Levin
9th IAS Conference on HIV Science (IAS 2017), July 23-26, 2017, Paris
IAS: MK-8591 Protects 8 of 8 Macaques From Rectal SHIV 6 Days After Dosing - (07/23/17)
Randolph P. Matthews1, Dirk Schurmann2, Deanne Jackson Rudd1, Vanessa Levine1, Sabrina Fox-Bosetti1, Sandra Zhang1, Martine Robberechts1, Inge De Lepeleire1, Andreas Huser2, Daria J. Hazuda1, Marian Iwamoto1, and Jay A. Grobler1 on behalf of the HIV Early Development Team. 1MSD, Kenilworth, NJ, USA; 2Charité Research Organisation, Berlin, Germany.